- The Europe infectious disease diagnostics market is driven by the rising prevalence of infectious diseases, increased awareness of early diagnosis benefits, and rapid adoption of molecular and point-of-care technologies. The COVID-19 pandemic significantly accelerated demand for fast, reliable diagnostic solutions and strengthened diagnostic infrastructure. Technological advancements—including multiplex testing, digital diagnostics, AI-based data analysis, and integration with healthcare IT systems—are propelling market growth. Furthermore, government initiatives focused on disease surveillance, antimicrobial resistance, and vaccination campaigns are expanding diagnostic testing requirements.
- The increasing healthcare expenditure, growing elderly population vulnerable to infections, and rising incidence of hospital-acquired infections further support market expansion. Cross-sector collaborations among public health agencies, hospitals, and diagnostic companies are also enhancing the availability and uptake of innovative diagnostics.
- Germany dominates the Infectious Disease Diagnostics market in Europe, holding the largest revenue share of 27.9% in 2025, fueled by its advanced healthcare infrastructure, strong diagnostics industry, and extensive research and development activities. The country’s proactive infectious disease management programs, favorable reimbursement policies, and high adoption of cutting-edge molecular platforms continue to drive market leadership.
- Germany is also projected to be the fastest-growing country in this market during the forecast period, supported by investments in high-throughput testing, digital diagnostic integration, and response readiness for emerging infectious diseases. The country’s focus on antimicrobial resistance monitoring and public health preparedness further stimulates market growth.
- Molecular diagnostics is expected to be the largest segment in Europe’s infectious disease diagnostics market with a significant share of 31.2% in 2025, due to its high sensitivity, specificity, and rapid turnaround. PCR and nucleic acid amplification techniques are widely used for detecting viruses and bacteria, including novel pathogens.
